Biotage AB (publ)

OM:BIOT 株式レポート

時価総額：SEK 14.9b

このページの翻訳は実験的なもので、現在開発中です。お待ちしております

Biotage マネジメント

マネジメント 基準チェック /14

現在、CEO に関する十分な情報がありません。

主要情報

Frederic Vanderhaegen

最高経営責任者

n/a

報酬総額

CEO給与比率n/a
CEO在任期間less than a year
CEOの所有権n/a
経営陣の平均在職期間3.8yrs
取締役会の平均在任期間2.8yrs

経営陣の近況

Recent updates

Investors Interested In Biotage AB (publ)'s (STO:BIOT) Earnings

Sep 17
Investors Interested In Biotage AB (publ)'s (STO:BIOT) Earnings

Biotage AB (publ) Just Missed EPS By 7.7%: Here's What Analysts Think Will Happen Next

Jul 19
Biotage AB (publ) Just Missed EPS By 7.7%: Here's What Analysts Think Will Happen Next

Are Investors Undervaluing Biotage AB (publ) (STO:BIOT) By 39%?

Jun 08
Are Investors Undervaluing Biotage AB (publ) (STO:BIOT) By 39%?

Is Biotage AB (publ) (STO:BIOT) Potentially Undervalued?

May 21
Is Biotage AB (publ) (STO:BIOT) Potentially Undervalued?

Revenue Beat: Biotage AB (publ) Exceeded Revenue Forecasts By 5.3% And Analysts Are Updating Their Estimates

Apr 28
Revenue Beat: Biotage AB (publ) Exceeded Revenue Forecasts By 5.3% And Analysts Are Updating Their Estimates

Biotage's (STO:BIOT) Dividend Will Be SEK1.60

Apr 17
Biotage's (STO:BIOT) Dividend Will Be SEK1.60

Biotage AB (publ) Just Beat EPS By 53%: Here's What Analysts Think Will Happen Next

Apr 08
Biotage AB (publ) Just Beat EPS By 53%: Here's What Analysts Think Will Happen Next

Biotage (STO:BIOT) Has Announced A Dividend Of SEK1.60

Apr 03
Biotage (STO:BIOT) Has Announced A Dividend Of SEK1.60

Biotage (STO:BIOT) Has Announced A Dividend Of SEK1.60

Mar 04
Biotage (STO:BIOT) Has Announced A Dividend Of SEK1.60

Weak Statutory Earnings May Not Tell The Whole Story For Biotage (STO:BIOT)

Feb 22
Weak Statutory Earnings May Not Tell The Whole Story For Biotage (STO:BIOT)

Subdued Growth No Barrier To Biotage AB (publ) (STO:BIOT) With Shares Advancing 32%

Feb 21
Subdued Growth No Barrier To Biotage AB (publ) (STO:BIOT) With Shares Advancing 32%

Biotage AB (publ) Just Recorded A 53% EPS Beat: Here's What Analysts Are Forecasting Next

Feb 18
Biotage AB (publ) Just Recorded A 53% EPS Beat: Here's What Analysts Are Forecasting Next

Biotage (STO:BIOT) Has A Pretty Healthy Balance Sheet

Feb 08
Biotage (STO:BIOT) Has A Pretty Healthy Balance Sheet

Investors Still Waiting For A Pull Back In Biotage AB (publ) (STO:BIOT)

Jan 07
Investors Still Waiting For A Pull Back In Biotage AB (publ) (STO:BIOT)

At kr124, Is It Time To Put Biotage AB (publ) (STO:BIOT) On Your Watch List?

Dec 08
At kr124, Is It Time To Put Biotage AB (publ) (STO:BIOT) On Your Watch List?

Estimating The Intrinsic Value Of Biotage AB (publ) (STO:BIOT)

Oct 27
Estimating The Intrinsic Value Of Biotage AB (publ) (STO:BIOT)

Does Biotage (STO:BIOT) Have A Healthy Balance Sheet?

Jul 12
Does Biotage (STO:BIOT) Have A Healthy Balance Sheet?

An Intrinsic Calculation For Biotage AB (publ) (STO:BIOT) Suggests It's 26% Undervalued

Jun 08
An Intrinsic Calculation For Biotage AB (publ) (STO:BIOT) Suggests It's 26% Undervalued

Biotage (STO:BIOT) Ticks All The Boxes When It Comes To Earnings Growth

May 24
Biotage (STO:BIOT) Ticks All The Boxes When It Comes To Earnings Growth

Biotage's (STO:BIOT) Upcoming Dividend Will Be Larger Than Last Year's

Apr 05
Biotage's (STO:BIOT) Upcoming Dividend Will Be Larger Than Last Year's

These 4 Measures Indicate That Biotage (STO:BIOT) Is Using Debt Safely

Mar 12
These 4 Measures Indicate That Biotage (STO:BIOT) Is Using Debt Safely

Is It Too Late To Consider Buying Biotage AB (publ) (STO:BIOT)?

Feb 21
Is It Too Late To Consider Buying Biotage AB (publ) (STO:BIOT)?

Are Biotage AB (publ) (STO:BIOT) Investors Paying Above The Intrinsic Value?

Jan 06
Are Biotage AB (publ) (STO:BIOT) Investors Paying Above The Intrinsic Value?

Biotage (STO:BIOT) Seems To Use Debt Rather Sparingly

Dec 03
Biotage (STO:BIOT) Seems To Use Debt Rather Sparingly

Is Now The Time To Look At Buying Biotage AB (publ) (STO:BIOT)?

Oct 27
Is Now The Time To Look At Buying Biotage AB (publ) (STO:BIOT)?

Estimating The Fair Value Of Biotage AB (publ) (STO:BIOT)

Oct 07
Estimating The Fair Value Of Biotage AB (publ) (STO:BIOT)

Biotage (STO:BIOT) Could Easily Take On More Debt

Sep 03
Biotage (STO:BIOT) Could Easily Take On More Debt

Is There Now An Opportunity In Biotage AB (publ) (STO:BIOT)?

Jul 10
Is There Now An Opportunity In Biotage AB (publ) (STO:BIOT)?

A Look At The Fair Value Of Biotage AB (publ) (STO:BIOT)

Jun 25
A Look At The Fair Value Of Biotage AB (publ) (STO:BIOT)

Do Biotage's (STO:BIOT) Earnings Warrant Your Attention?

May 28
Do Biotage's (STO:BIOT) Earnings Warrant Your Attention?

Biotage's (STO:BIOT) Upcoming Dividend Will Be Larger Than Last Year's

Apr 23
Biotage's (STO:BIOT) Upcoming Dividend Will Be Larger Than Last Year's

Biotage (STO:BIOT) Is Paying Out A Larger Dividend Than Last Year

Mar 29
Biotage (STO:BIOT) Is Paying Out A Larger Dividend Than Last Year

Does Biotage (STO:BIOT) Have A Healthy Balance Sheet?

Mar 14
Does Biotage (STO:BIOT) Have A Healthy Balance Sheet?

CEO（最高経営責任者

Frederic Vanderhaegen (57 yo)

less than a year

在職期間

Mr. Frederic Vanderhaegen was Executive Vice President of Europe of Avantor, Inc. from October 2022 until 2024. He was Executive Vice President of Americas & Europe of Avantor, Inc. from September 22, 2020...

リーダーシップ・チーム

名称ポジション在職期間報酬所有権
Frederic Vanderhaegen
Chief Executive Officerless than a yearデータなしデータなし
Andrew Kellett
Chief Financial Officer1.1yrsデータなしデータなし
Anders Wikstrom
Executive Vice President of Operations14.4yrsデータなし0.0064%
SEK 959.5k
Raffaella Bombarda
EVP of Global Marketingno dataデータなしデータなし
Petra Duprez
Chief Human Resources & Sustainability Officerno dataデータなし0.019%
SEK 2.8m
Scott Carr
President of Americas & Chief/Head of Americasno dataデータなし0.010%
SEK 1.5m
Jonas Stahlberg
Chief Auditorno dataデータなしデータなし
Olof Nord
Executive Vice President of Business Developmentno dataデータなし0.025%
SEK 3.8m
Andreas Juhlin
President of International - EMEA and APAC4.3yrsデータなし0.0064%
SEK 959.5k
Magnus Nordstedt
Executive Vice President of IT & Digitalizationno dataデータなし0.0059%
SEK 875.8k
Lisa Egelrud
Executive Vice President of Quality Assurance & Regulatory Affairs3.8yrsデータなしデータなし
Maryam Poorafshar
Executive Vice President R&Dno dataデータなしデータなし

3.8yrs

平均在職期間

52.5yo

平均年齢

経験豊富な経営陣: BIOTの経営陣は 経験豊富 であると考えられます ( 3.6年の平均在職年数)。

取締役

名称ポジション在職期間報酬所有権
Torben Jorgensen
Director4.9yrsSEK 857.00k0.40%
SEK 59.8m
Kieran Murphy
Chairman1.5yrsSEK 227.00kデータなし
Peter von Ehrenheim
Director11.5yrsSEK 407.00k0.020%
SEK 3.0m
Asa Hedin
Director4.9yrsSEK 337.00kデータなし
Mark Bradley
Director5.5yrsSEK 307.00kデータなし
Kugan Sathiyanandarajah
Director1.5yrsデータなしデータなし
Dan Menasco
Employee Representative Director2.8yrsデータなしデータなし
Karen Soerensen
Director2.5yrsSEK 357.00kデータなし
Par Lundgren
Employee Representative Directorno dataデータなしデータなし
Philip Lamberstam
Employee Representative Directorless than a yearデータなしデータなし

2.8yrs

平均在職期間

61.5yo

平均年齢

経験豊富なボード: BIOTの 取締役会 は 経験豊富 ではない ( 2.7年の平均在任期間) ため、新しい取締役会が必要であると考えられます。